NSE filing, NSE: FAZE3Q. Summary written from the filing by ALFA Finder's alert engine.
Faze Three Ltd: key numbers
- Share price
- ₹410.00
- Market cap
- ₹1,009 Cr
- Revenue (annual)
- ₹923.1 Cr
- Net profit (annual)
- ₹33.57 Cr
- P/E (TTM)
- 33.1×Sector 49.5×
- Promoter holding
- 57.35%-0.66% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Faze Three Ltd
All →Faze Three Other Announcement
Faze Three Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, including an explanatory note regarding ESOP Trust shareholding adjustments.
Faze Three Business Update
Faze Three Limited informed the exchange about an interview of its President, Vishnu Anand, published in Dun & Bradstreet's 'Business Enterprises of Tomorrow' report.
Faze Three Management Change
Faze Three Limited has appointed Mr. Mohit Dinesh Solanki as an Independent Director for a five-year term effective August 17, 2026. The appointment was approved at the AGM.
Faze Three Annual General Meeting
Faze Three Limited concluded its 41st Annual General Meeting on September 4, 2026. Shareholders transacted ordinary and special business resolutions.
Faze Three Annual Report
Faze Three Limited submitted its 41st Annual Report for FY 2025-26 and the Notice convening the 41st Annual General Meeting scheduled for September 04, 2026.
Faze Three Annual General Meeting
Faze Three Limited issued a notice for its 41st Annual General Meeting on September 4, 2026. The agenda includes director appointments and borrowing limit approvals.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.